Ms Bella North > McDermott Will & Emery UK LLP > London, England > Lawyer Profile
McDermott Will & Emery UK LLP Offices
22 Bishopsgate
London
EC2N 4BQ
England
- Firm Profile
- Go to...
Ms Bella North
Work Department
Healthcare
Position
Bella North focuses her practice on advising clients in the healthcare and life sciences sectors in the context of transactions (M&A, joint ventures and private equity) and regulatory (compliance and strategy).
Bella is experienced in helping clients enter and navigate the UK healthcare and life sciences market, including those seeking to establish digital health platforms, develop cross-border telemedicine, and provide direct-to-consumer services. She also works closely with clients managing compliance issues in the context of healthcare services, clinical trials and investigations and health data.
Bella brings experience in UK public sector healthcare, regularly advising providers on clinical governance and professional healthcare practice.
Read full biography here: https://www.mwe.com/people/bella-north/
Lawyer Rankings
London > Industry focus > Life sciences and healthcare
Lauded for advice that ‘balances the risks and benefits of any given approach clearly’, McDermott Will & Emery UK LLP is active across regulatory matters such as medical device certifications and transactional work spanning M&A, IP transfers and growth capital investments. Sharon Lamb heads up the team and has a far-reaching practice spanning commercial, regulatory and transactional expertise. Hamid Yunis is a key contact for private equity transactions. Michal Berkner, who joined from Cooley (UK) LLP in February 2024, further bolsters the team’s transactional capacities and counts takeover defences, corporate governance, and joint ventures among her practice strengths. David Gibson and Bella North are further key names to note.
Lawyer Rankings
Top Tier Firm Rankings
- Real estate > Commercial property: investment
- Corporate and commercial > M&A: Lower Mid-Market Deals, £100m-£750m
Firm Rankings
- Dispute resolution > Commercial litigation: mid-market
- Private client > Contentious trusts and probate
- Finance > Debt capital markets
- Industry focus > Emerging markets
- Industry focus > Life sciences and healthcare
- Corporate and commercial > M&A: Lower Mid-Market Deals, £100m-£750m
- Private client > Personal tax, trusts and probate
- Finance > Acquisition finance
- Finance > Derivatives and structured products
- Risk advisory > ESG
- Finance > High yield
- Dispute resolution > International arbitration
- Corporate and commercial > Private equity: transactions - mid-market deals (up to £500m)
- Risk advisory > Regulatory investigations and corporate crime (advice to corporates)
- Finance > Bank lending: investment grade debt and syndicated loans
- Finance > Corporate restructuring & insolvency
- Corporate and commercial > Corporate tax
- Real estate > Property finance
- Projects, energy and natural resources > Renewables
- Employment > Employers